Adults
Always follow exactly the medication administration instructions contained in this leaflet or those indicated by your doctor, pharmacist, or nurse. If in doubt, ask your doctor, pharmacist, or nurse.
The recommended dose is one film-coated tablet (600 mg) twice a day (every 12 hours). Swallow the film-coated tablet whole with a little water.
If you are on dialysis, take linezolid after each session.
The normal treatment duration is 10-14 days, but it may be extended up to 28 days. The safety and efficacy of this medication have not been established in treatment periods exceeding 28 days. Your doctor will decide on the duration of your treatment.
While taking linezolid, your doctor will perform periodic blood tests to monitor your blood count.
If you take linezolid for more than 28 days, your doctor will monitor your vision.
Use in children and adolescents
Linezolid is not normally used in children or adolescents (under 18 years).
If you take more Apel than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forgot to take Apel
Take the missed tablet as soon as you remember. Take the next tablet 12 hours later and continue taking the tablets every 12 hours.Do not take a double dose to make up for the missed dose.
If you interrupt treatment with Apel
It is essential that you only interrupt your treatment if your doctor instructs you to do so. If your initial symptoms return after interrupting your treatment, inform your doctor or pharmacist immediately.
If you have any other questions about the use of this medication, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Inform your doctor, nurse or pharmacist immediatelyif you notice any of the following side effects while taking linezolid:
There have been reports of numbness, tingling or blurred vision in patients who have taken linezolid for more than 28 days. If you experience vision difficulties, consult your doctor as soon as possible.
Other side effects include:
Frequent(may affect up to 1 in 10 people):
Occasional(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
Also, the following side effects have been reported(unknown: the frequency cannot be estimated from available data):
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through theSpanish System for Pharmacovigilance of Medicinal Products for Human Use:www.notificaRAM.es.
By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keepthis medicationout of the sight and reach of children.
This medication does not require special storage conditions.
Do not usethis medicationafter the expiration date that appears onthe boxafter CAD. The expiration date is the last day of the month indicated.
Medicines should not be thrown down the drain or in the trash. Dispose of the packaging and unused medications at thePharmacy Take-Backpoint. By doing so, you will help protect the environment.
Composition of Apel
Appearance of the product and contents of the packaging
The film-coated tablets are white, oval, biconvex, flat on both sides with dimensions of 18 x 9 mm.
The packaging contains opaque PVC/PVDC-Alu blisters with 10, 14, 20, 24, 30, 50, 60 or 100 film-coated tablets.
Only some sizes of packaging may be commercially available.
Marketing Authorization Holder
Medochemie Ltd
1-10 Constantinoupoleos street
3011 Limassol,
Cyprus
Responsible for Manufacturing
Medochemie Ltd, Factory AZ
2 Michael Erakleous Street,
Agios Athanassios Industrial Area,
Agios Athanassios, Limassol, 4101
Cyprus
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
Medochemie Iberia S.A., Sucursal en España
Avenida de las Águilas, nº 2 B; planta 5 oficina 6,
28044Madrid
SPAIN
Last review date of thisleaflet:September 2018
The detailed information about this medicine is available on the website of the {Spanish Agency of Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/).
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.